查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1492497

伊文氏肉瘤治療市場：按治療、階段、適應症、最終用戶、分銷管道 - 全球預測 2024-2030

Ewing Sarcoma Therapeutics Market by Treatment (Chemotherapy, Radiation Therapy, Surgery), Stage of Disease (Localized Ewing Sarcoma, Metastatic Ewing Sarcoma), Indication, End-User, Distribution Channel - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

伊文氏肉瘤治療市場規模預計2023年為10.1億美元，2024年達到10.8億美元，預計2030年將達到16.1億美元，複合年成長率為6.83%。

伊文氏肉瘤是一種影響骨骼及其周圍軟組織的癌症，最常見於兒童和年輕人。伊文氏肉瘤治療包括用於對抗此類癌症的治療方法和策略，例如化療、放射線治療、手術和標靶治療。伊文氏肉瘤盛行率的不斷增加增加了對與伊文氏肉瘤相關的各種診斷和治療工具的需求，以進行有效的治療。加強對伊文氏肉瘤的認知計劃和教育正在增加對早期診斷的需求，這對於有效治療至關重要。這種認可也促進了公共和私人資助新治療方法的研究。與伊文氏肉瘤相關的高治療成本阻礙了市場成長。增加對伊文氏肉瘤新治療方法研發的投資，這種療法副作用可能更少，預計將為市場成長創造機會。

主要市場統計
基準年[2023] 10.1億美元
預測年份 [2024] 10.8億美元
預測年份 [2030] 16.1億美元
複合年成長率（%） 6.83%

區域洞察

美洲市場擁有先進的醫療設施和對癌症研究的大量投資，使其成為開發和採用伊文氏肉瘤等疾病新治療方法的重要地區。在美國、巴西、墨西哥和加拿大，政府和私人對醫學研究的大力支持正在幫助加快監管核准並提高意識和治療率。亞太地區的醫療基礎設施正在快速成長，醫學研究投資也在增加。中國、日本和澳洲等國家正在透過臨床試驗和合作研究為伊文氏肉瘤研究做出貢獻。歐洲、中東和非洲的市場多種多樣，因為醫療保健系統和經濟狀況差異很大。西歐國家擁有先進的醫療設施和研究系統，為市場供應商提供了開發伊文氏肉瘤新治療方法的機會。提高對伊文氏肉瘤治療方法的認知是中東和非洲市場成長的基礎。然而，中東和非洲面臨阻礙新治療方法採用的挑戰，包括醫療投資下降和可近性問題。

FPNV定位矩陣

FPNV 定位矩陣對於評估伊文氏肉瘤治療市場供應商的定位至關重要。此矩陣提供了對供應商的全面評估，並檢查了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對伊文氏肉瘤治療市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該行業競爭力的寶貴見解，包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。伊文氏肉瘤治療市場目前地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球伊文氏肉瘤盛行率增加
      • 加強對伊文氏肉瘤的認知計畫和教育
    • 抑制因素
      • 伊文氏肉瘤的治療費用很高。
    • 機會
      • 擴大研究和開發力度，引入伊文氏肉瘤的有效治療方法
      • 伊文氏肉瘤標靶治療的潛力增加
    • 任務
      • 伊文氏肉瘤- 特定藥物開發與製造的複雜性
  • 市場區隔分析
    • 治療：越來越需要放射線治療來消滅癌細胞
    • 最終使用者：透過醫院和診所輕鬆取得伊文氏肉瘤藥物
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章伊文氏肉瘤藥物市場（依治療）

  • 化療
  • 放射治療
  • 外科手術
  • 標靶治療

第7章依疾病階段伊文氏肉瘤治療藥物市場

  • 局部伊文氏肉瘤
  • 轉移性伊文氏肉瘤

第8章伊文氏肉瘤治療藥物市場（按適應症）

  • 阿斯金瘤
  • 骨腫瘤
  • 週邊原始神經外胚層腫瘤
  • 軟組織腫瘤

第9章伊文氏肉瘤治療藥物市場：依最終用戶分類

  • 癌症治療中心
  • 醫院/診所

第10章伊文氏肉瘤治療藥物市場：按分銷管道

  • 醫院藥房
  • 網路藥房

第11章美洲伊文氏肉瘤治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區伊文氏肉瘤治療藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲伊文氏肉瘤藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
    • Inhiflex 報告治療伊文氏肉瘤的第一期研究結果取得進展
    • 住友製藥腫瘤公司的TP-1287被指定為治療伊文氏肉瘤的孤兒藥
    • 奈米醫學在伊文氏肉瘤個人化治療方面取得突破
  • 戰略分析和建議

第15章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-CB04E05652A3

[193 Pages Report] The Ewing Sarcoma Therapeutics Market size was estimated at USD 1.01 billion in 2023 and expected to reach USD 1.08 billion in 2024, at a CAGR 6.83% to reach USD 1.61 billion by 2030.

Ewing sarcoma is a type of cancer that affects bones and the soft tissue around bones and is most commonly found in children and young adults. Ewing sarcoma therapeutics includes the treatments and strategies used to combat this form of cancer, which include chemotherapy, radiation therapy, surgery, and targeted therapies. The increasing prevalence of Ewing sarcoma is raising the need for various diagnostic and treatment tools associated with Ewing sarcoma for effective treatment. Increasing awareness programs and education about Ewing sarcoma increases the need for early diagnosis rates, which is critical for effective treatment. This awareness also drives public and private funding for research into new therapies. The high cost of treatments associated with Ewing sarcoma hampers the market growth. Growing investment in researching and developing new treatments for Ewing Sarcoma with potentially fewer side effects is expected to create opportunities for market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 1.01 billion
Estimated Year [2024] USD 1.08 billion
Forecast Year [2030] USD 1.61 billion
CAGR (%) 6.83%

Regional Insights

The market in the Americas has advanced healthcare facilities and significant investments in cancer research, making it a significant region for developing and adopting new therapies for diseases, including Ewing sarcoma. Strong governmental and private support for medical research in the United States, Brazil, Mexico, and Canada contributes to faster regulatory approvals and higher awareness and treatment rates. The Asia-Pacific region is seeing rapid growth in healthcare infrastructure and increased medical research investments. Countries such as China, Japan, and Australia contribute to Ewing sarcoma research through clinical trials and research collaborations. The market is diverse in Europe, the Middle East, and Africa due to significant variations in healthcare systems and economic conditions. Western European countries, with their advanced medical facilities and research frameworks, are creating opportunities for market vendors to develop novel Ewing sarcoma treatments. Rising awareness associated with available treatments for Ewing sarcoma is creating a platform for market growth in the Middle East and Africa. However, the Middle East and Africa face challenges, including lower healthcare investment and accessibility issues, which hinder the adoption of new treatments.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Ewing Sarcoma Therapeutics Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising prevalence of Ewing Sarcoma worldwide
      • Increasing awareness programs and education about Ewing sarcoma
    • Market Restraints
      • High cost of Ewing sarcoma treatments
    • Market Opportunities
      • Growing research & development activities to introduce effective Ewing sarcoma treatments
      • Increasing potential for targeted therapy for Ewing sarcoma
    • Market Challenges
      • Complexities in drug development and manufacturing specific to Ewing sarcoma
  • Market Segmentation Analysis
    • Treatment: Growing need for radiation therapy to destroy cancer cells
    • End-User: High accessibility of Ewing sarcoma therapeutics through hospitals & clinics
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Ewing Sarcoma Therapeutics Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Ewing Sarcoma Therapeutics Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Inhibrx Reports Progress in Ewing Sarcoma Treatment with Phase 1 Trial Results

Inhibrx, Inc. disclosed preliminary efficacy and safety outcomes from its Phase 1 study involving INBRX-109, used alongside Irinotecan and Temozolomide (IRI/TMZ), targeting advanced or metastatic, unresectable Ewing sarcoma. The findings, presented at the Annual Connective Tissue Oncology Society (CTOS) Conference on September 8th, 2023, mark a significant step in therapeutic development for this challenging cancer type, highlighting Inhibrx's commitment to advancing cancer treatment. [Published On: 2023-11-02]

Orphan Drug Designation Awarded to Sumitomo Pharma Oncology's TP-1287 for Ewing Sarcoma Treatment

Sumitomo Pharma Oncology, Inc. gained Orphan Drug Designation from the U.S. FDA for its drug candidate TP-1287, a CDK9 inhibitor administered orally to treat Ewing sarcoma. The FDA's Orphan Drug Designation is awarded to drugs under development for the treatment of rare medical conditions affecting less than 200,000 individuals in the U.S. [Published On: 2023-04-10]

Breakthrough in Personalized Treatment for Ewing Sarcoma Using Nanomedicine

Scientists at the SJD Pediatric Cancer Center Barcelona, a part of SJD Barcelona Children's Hospital, have significantly improved treatment of Ewing sarcoma. This severe form of cancer, primarily affecting children and adolescents' bones and soft tissues, shows variability in treatment response based on the presence of specific proteins in cancer cells. The researchers have found that Ewing sarcoma tumors lacking the Bcl-2 protein respond positively to nab-paclitaxel, a well-established nanomedicine. [Published On: 2023-02-23]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Ewing Sarcoma Therapeutics Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Ewing Sarcoma Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amgen Inc., Amneal Pharmaceuticals Inc., AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Johnson and Johnson, Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A., and Sumitomo Pharma Oncology, Inc..

Market Segmentation & Coverage

This research report categorizes the Ewing Sarcoma Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Treatment
    • Chemotherapy
    • Radiation Therapy
    • Surgery
    • Targeted Therapy
  • Stage of Disease
    • Localized Ewing Sarcoma
    • Metastatic Ewing Sarcoma
  • Indication
    • Askin Tumor
    • Bone Tumor
    • Peripheral Primitive Neuroectodermal Tumor
    • Soft Tissue Tumor
  • End-User
    • Cancer Treatment Centers
    • Hospitals & Clinics
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of Ewing Sarcoma worldwide
      • 5.1.1.2. Increasing awareness programs and education about Ewing sarcoma
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of Ewing sarcoma treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing research & development activities to introduce effective Ewing sarcoma treatments
      • 5.1.3.2. Increasing potential for targeted therapy for Ewing sarcoma
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities in drug development and manufacturing specific to Ewing sarcoma
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Treatment: Growing need for radiation therapy to destroy cancer cells
    • 5.2.2. End-User: High accessibility of Ewing sarcoma therapeutics through hospitals & clinics
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Ewing Sarcoma Therapeutics Market, by Treatment

  • 6.1. Introduction
  • 6.2. Chemotherapy
  • 6.3. Radiation Therapy
  • 6.4. Surgery
  • 6.5. Targeted Therapy

7. Ewing Sarcoma Therapeutics Market, by Stage of Disease

  • 7.1. Introduction
  • 7.2. Localized Ewing Sarcoma
  • 7.3. Metastatic Ewing Sarcoma

8. Ewing Sarcoma Therapeutics Market, by Indication

  • 8.1. Introduction
  • 8.2. Askin Tumor
  • 8.3. Bone Tumor
  • 8.4. Peripheral Primitive Neuroectodermal Tumor
  • 8.5. Soft Tissue Tumor

9. Ewing Sarcoma Therapeutics Market, by End-User

  • 9.1. Introduction
  • 9.2. Cancer Treatment Centers
  • 9.3. Hospitals & Clinics

10. Ewing Sarcoma Therapeutics Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Hospital Pharmacies
  • 10.3. Online Pharmacies

11. Americas Ewing Sarcoma Therapeutics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Ewing Sarcoma Therapeutics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Ewing Sarcoma Therapeutics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Inhibrx Reports Progress in Ewing Sarcoma Treatment with Phase 1 Trial Results
    • 14.3.2. Orphan Drug Designation Awarded to Sumitomo Pharma Oncology's TP-1287 for Ewing Sarcoma Treatment
    • 14.3.3. Breakthrough in Personalized Treatment for Ewing Sarcoma Using Nanomedicine
  • 14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. EWING SARCOMA THERAPEUTICS MARKET RESEARCH PROCESS
  • FIGURE 2. EWING SARCOMA THERAPEUTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. EWING SARCOMA THERAPEUTICS MARKET DYNAMICS
  • FIGURE 7. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS EWING SARCOMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS EWING SARCOMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC EWING SARCOMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC EWING SARCOMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. EWING SARCOMA THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. EWING SARCOMA THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EWING SARCOMA THERAPEUTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY LOCALIZED EWING SARCOMA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY LOCALIZED EWING SARCOMA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY METASTATIC EWING SARCOMA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY METASTATIC EWING SARCOMA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY ASKIN TUMOR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY ASKIN TUMOR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY BONE TUMOR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY BONE TUMOR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY SOFT TISSUE TUMOR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY SOFT TISSUE TUMOR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY CANCER TREATMENT CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY CANCER TREATMENT CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS EWING SARCOMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS EWING SARCOMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 77. CANADA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 78. CANADA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 81. CANADA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 82. CANADA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 87. MEXICO EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 88. MEXICO EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 89. MEXICO EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 90. MEXICO EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 91. MEXICO EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 92. MEXICO EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 97. UNITED STATES EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 98. UNITED STATES EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 99. UNITED STATES EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 100. UNITED STATES EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 101. UNITED STATES EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 102. UNITED STATES EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC EWING SARCOMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC EWING SARCOMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 122. AUSTRALIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 124. AUSTRALIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 126. AUSTRALIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 131. CHINA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 132. CHINA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 133. CHINA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 134. CHINA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 135. CHINA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 136. CHINA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 141. INDIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 142. INDIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 143. INDIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 144. INDIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 145. INDIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 146. INDIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 151. INDONESIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 152. INDONESIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 153. INDONESIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 154. INDONESIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 155. INDONESIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 156. INDONESIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 161. JAPAN EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 162. JAPAN EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 163. JAPAN EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 164. JAPAN EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 165. JAPAN EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 166. JAPAN EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 171. MALAYSIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 172. MALAYSIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 173. MALAYSIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 174. MALAYSIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 175. MALAYSIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 176. MALAYSIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 182. PHILIPPINES EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 184. PHILIPPINES EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 186. PHILIPPINES EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 191. SINGAPORE EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 192. SINGAPORE EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 193. SINGAPORE EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 194. SINGAPORE EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 195. SINGAPORE EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 196. SINGAPORE EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 202. SOUTH KOREA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 204. SOUTH KOREA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 206. SOUTH KOREA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 211. TAIWAN EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 212. TAIWAN EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 213. TAIWAN EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 214. TAIWAN EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 215. TAIWAN EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 216. TAIWAN EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 221. THAILAND EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 222. THAILAND EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 223. THAILAND EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 224. THAILAND EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 225. THAILAND EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 226. THAILAND EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 231. VIETNAM EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 232. VIETNAM EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 233. VIETNAM EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 234. VIETNAM EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 235. VIETNAM EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 236. VIETNAM EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA EWING SARCOMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 253. DENMARK EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 254. DENMARK EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 255. DENMARK EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 256. DENMARK EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 257. DENMARK EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 258. DENMARK EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 263. EGYPT EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 264. EGYPT EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 265. EGYPT EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 266. EGYPT EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 267. EGYPT EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 268. EGYPT EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 273. FINLAND EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 274. FINLAND EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 275. FINLAND EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 276. FINLAND EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 277. FINLAND EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 278. FINLAND EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 283. FRANCE EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 284. FRANCE EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 285. FRANCE EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 286. FRANCE EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 287. FRANCE EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 288. FRANCE EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 289. FRANCE EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 290. FRANCE EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 291. FRANCE EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 292. FRANCE EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 293. GERMANY EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 294. GERMANY EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 295. GERMANY EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 296. GERMANY EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 297. GERMANY EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 298. GERMANY EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 299. GERMANY EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 300. GERMANY EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 301. GERMANY EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 302. GERMANY EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 303. ISRAEL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 304. ISRAEL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 305. ISRAEL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 306. ISRAEL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 307. ISRAEL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 308. ISRAEL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 309. ISRAEL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 310. ISRAEL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 311. ISRAEL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 312. ISRAEL EWING SARCOMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 313. ITALY EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 314. ITALY EWING SARCOMA THERAPEUTICS MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 315. ITALY EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2018-2023 (USD MILLION)
  • TABLE 316. ITALY EWING SARCOMA THERAPEUTICS MARKET SIZE, BY STAGE OF DISEASE, 2024-2030 (USD MILLION)
  • TABLE 317. ITALY EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 318. ITALY EWING SARCOMA THERAPEUTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 319. ITALY EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 320. ITALY EWING SARCOMA THERAPEUTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 321. ITALY EW